Tag:
Covidien
Latest Headlines
Latest Headlines
Covidien recalls Roticulator staplers
Covidien is recalling its Roticulator staplers around the world, citing a packaging issue that might have rendered some products non-sterile.
Covidien grabs Maya Medical for $60M-plus
Covidien ($COV) has forked over $60 million for Maya Medical, a California developer of a renal denervation treatment Covidien said it will be unveiling at the EuroPCR congress in Paris, France on May 16.
Covidien, GE Healthcare to blend patient monitoring system tech
Covidien ($COV) and GE Healthcare are forming one of those trusty "global collaboration" deals, this time to expand production of beefed-up patient monitoring systems.
Covidien closes $108M bid for Newport Medical
After 6 weeks and $108 million spent, Covidien ($COV) is the proud new owner of Newport Medical Instruments in what is becoming another heady year of acquisitions for its device division.
Covidien acquires Israeli maker of hernia mesh placement device
Covidien ($COV) has snatched up an Israeli startup that developed a device to place hernia mesh laparoscopically.
Covidien sees strong quarter on device sales, emerging markets growth
Earnings season continues, and this morning, Covidien ($COV) released positive results in a quarter that witnessed a 7% rise in device sales.
Top 10 Medical Device R&D Budgets
In the face of a sluggish economy barely recovering from its historic collapse in 2008, almost all of the companies made a concerted effort to boost their R&D spending during their 2011 fiscal years.
Covidien to snap up Oridion for about $346M
This morning, Covidien announced a definitive agreement to acquire Jerusalem-based Oridion Systems in a deal valued at about $346 million.
Oridion picked up by Covidien, still under partial FDA ban
With the $346 million acquisition of Israeli device maker Oridion Systems, Covidien is getting a company still operating under an FDA import restriction.
Covidien scoops up pulmonary devicemaker for $300M
Covidien ( $COV ) is on the acquisition trail again. This time, it has picked up Israel's superDimension for $300 million plus future performance-based payouts.
